What's Delaying The Move Toward Biopharma 4.0?

We have all heard the urgent prophecy of Biopharma 4.0 – several times by now. We have patiently listened to the grand vision of smart processes that continuously learn from data, optimize conditions and predict the future, all in a couple of seconds. A promise of a coming enterprise-wide network that promotes communication and strategic insight, while controlling manufacturing, logistics and supply chains – for shorter time-to-market at lower cost. According to research by McKinsey, the biopharmaceutical industry could achieve a whopping 40% gain in productivity by this imminent paradigm shift.

So, what's the hold up?